180 related articles for article (PubMed ID: 21199886)
21. An individual reference limit for 'early' diagnosis of metastatic breast cancer during postoperative follow-up.
Nicolini A; Ferrari P; Fulceri F; Carpi A; Rossi G
Biomark Med; 2015; 9(4):307-17. PubMed ID: 25808435
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.
Janni W; Gastroph S; Hepp F; Kentenich C; Rjosk D; Schindlbeck C; Dimpfl T; Sommer H; Braun S
Cancer; 2000 May; 88(10):2252-9. PubMed ID: 10820346
[TBL] [Abstract][Full Text] [Related]
23. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
24. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
25. Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.
Vignoli A; Risi E; McCartney A; Migliaccio I; Moretti E; Malorni L; Luchinat C; Biganzoli L; Tenori L
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925233
[TBL] [Abstract][Full Text] [Related]
26. Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.
Kus K; Kij A; Zakrzewska A; Jasztal A; Stojak M; Walczak M; Chlopicki S
Breast Cancer Res; 2018 Dec; 20(1):148. PubMed ID: 30514398
[TBL] [Abstract][Full Text] [Related]
27. Metabolomics in breast cancer: A decade in review.
McCartney A; Vignoli A; Biganzoli L; Love R; Tenori L; Luchinat C; Di Leo A
Cancer Treat Rev; 2018 Jun; 67():88-96. PubMed ID: 29775779
[TBL] [Abstract][Full Text] [Related]
28. Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery.
Li S; Yan W; Yang X; Chen L; Fan L; Liu H; Liu K; Zhang Y; Jiang J
BMC Cancer; 2019 Nov; 19(1):1070. PubMed ID: 31703643
[TBL] [Abstract][Full Text] [Related]
29. Postoperative recurrence analysis of breast cancer patients based on clinical serum markers using discriminant methods.
Li L; Gao Q; Xu G; Shi B; Ma X; Liu H; Li Q; Tian T; Tang J; Niu H
Cancer Biomark; 2017 Jul; 19(4):403-409. PubMed ID: 28582844
[TBL] [Abstract][Full Text] [Related]
30. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer.
Iqbal J; Ginsburg O; Giannakeas V; Rochon PA; Semple JL; Narod SA
Breast Cancer Res Treat; 2017 Jan; 161(1):103-115. PubMed ID: 27796715
[TBL] [Abstract][Full Text] [Related]
31. Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer.
Zhang X; Zhao W; Wei W; You Z; Ou X; Sun M; Yin Y; Tang X; Zhao Z; Hu C; Liu F; Deng J; Mao L; Zhou D; Ren Y; Li X; Zhang S; Liu C; Geng J; Yao G; Song B; Liu Y; Li D; Jiang Y; Chen Y; Zhao Y; Yu S; Pang D
Clin Cancer Res; 2019 Nov; 25(21):6546-6553. PubMed ID: 31350313
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics in Breast Cancer: Current Status and Perspectives.
Hart CD; Tenori L; Luchinat C; Di Leo A
Adv Exp Med Biol; 2016; 882():217-34. PubMed ID: 26987537
[TBL] [Abstract][Full Text] [Related]
33. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
[TBL] [Abstract][Full Text] [Related]
34. A new insight on serum microRNA expression as novel biomarkers in breast cancer patients.
Bahmanpour Z; Sheervalilou R; Choupani J; Shekari Khaniani M; Montazeri V; Mansoori Derakhshan S
J Cell Physiol; 2019 Nov; 234(11):19199-19211. PubMed ID: 31026062
[TBL] [Abstract][Full Text] [Related]
35. The emerging role of circulating tumor cells in breast cancer.
Krishnamurthy S
Cancer Cytopathol; 2012 Jun; 120(3):161-6. PubMed ID: 22275137
[No Abstract] [Full Text] [Related]
36. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
37. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
38. Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure.
Padeletti L; Modesti PA; Cartei S; Checchi L; Ricciardi G; Pieragnolia P; Sacchi S; Padeletti M; Alterini B; Pantaleo P; Hu X; Tenori L; Luchinat C
J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):295-300. PubMed ID: 24699011
[TBL] [Abstract][Full Text] [Related]
39. A prognostic fingerprint in liver transplantation for hepatocellular carcinoma based on plasma metabolomics profiling.
Lu D; Yang F; Lin Z; Zhuo J; Liu P; Cen B; Lian Z; Xie H; Zheng S; Xu X
Eur J Surg Oncol; 2019 Dec; 45(12):2347-2352. PubMed ID: 31331801
[TBL] [Abstract][Full Text] [Related]
40. Uncovering the metabolomic fingerprint of breast cancer.
Oakman C; Tenori L; Biganzoli L; Santarpia L; Cappadona S; Luchinat C; Di Leo A
Int J Biochem Cell Biol; 2011 Jul; 43(7):1010-20. PubMed ID: 20460168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
